Haya Therapeutics in a $65M series A with Sofinnova Partners, Schroders Capital, +ND Capital,
02 May 2025
02 May 2025
Total investments received (USD): 65M
Round value (USD): 65M
Company: Haya Therapeutics
Related deals
Polares Medical secures $50 million Series C financing with DC Global Ventures, Lumination Partners
Investments
01 March 2026
FoRx raises $50 million series A with EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund and M Ventures
Investments
08 December 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal